Activity-guided isolation of NF-κB inhibitors and PPARγ agonists from the root bark of Lycium chinense Miller
The root bark of Lycium chinense Miller, Lycii Radicis Cortex, has been used in traditional Chinese medicine (TCM) to treat different inflammation-related symptoms, such as diabetes mellitus. The pro-inflammatory transcription factor nuclear factor kappa B (NF-κB) is a key regulator of inflammation,...
Gespeichert in:
Veröffentlicht in: | Journal of ethnopharmacology 2014-03, Vol.152 (3), p.470-477 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 477 |
---|---|
container_issue | 3 |
container_start_page | 470 |
container_title | Journal of ethnopharmacology |
container_volume | 152 |
creator | Xie, Lian-Wu Atanasov, Atanas G. Guo, De-An Malainer, Clemens Zhang, Jing-Xian Zehl, Martin Guan, Shu-Hong Heiss, Elke H. Urban, Ernst Dirsch, Verena M. Kopp, Brigitte |
description | The root bark of Lycium chinense Miller, Lycii Radicis Cortex, has been used in traditional Chinese medicine (TCM) to treat different inflammation-related symptoms, such as diabetes mellitus. The pro-inflammatory transcription factor nuclear factor kappa B (NF-κB) is a key regulator of inflammation, while the transcription factor peroxisome proliferator-activated receptor gamma (PPARγ) is a key modulator of genes involved in diabetes development. To identify putative active compound(s) from Lycii Radicis Cortex inhibiting NF-κB or activating PPARγ.
Using activity-guided fractionation, six extracts with different polarity, isolated fractions, and purified compounds from Lycii Radicis Cortex were tested for NF-κB inhibition and PPARγ activation in vitro. The structure of the purified compounds was elucidated by NMR and MS techniques.
The ethyl acetate extract and the methanol extract of Lycii Radicis Cortex suppressed tumor necrosis factor alpha (TNF-α)-induced activation of NF-κB, while the dichloromethane extract activated PPARγ. Nine phenolic amide analogues, including trans-N-(p-coumaroyl)tyramine (1), trans-N-feruloyltyramine (2), trans-N-caffeoyltyramine (3), dihydro-N-caffeoyltyramine (4), three neolignanamides (5–7), and two lignanamide (8, 9), were isolated and their inhibitory potential on NF-κB was determined (1–4 were also contained in water decoction). Two of the nine isolated phenolic amides inhibited TNF-α-induced NF-κB activation. Trans-N-caffeoyltyramine was verified as the key component responsible for the NF-κB inhibition with an IC50 of 18.4μM in our cell-based test system. Activation of PPARγ was attributed to a palmitic-acid enriched fraction which displayed concentration-dependent effect ablated upon co-treatment with the PPARγ antagonist T0070907.
Phenolic amides were confirmed as main components from Lycii Radicis Cortex responsible for NF-κB inhibition. Fatty acids were identified as the major plant constituent responsible for the PPARγ activation. Structure-activity relationship analysis suggests that the NF-κB inhibitory activity of trans-N-caffeoyltyramine may be attributed to its Michael acceptor-type structure (α,β-unsaturated carbonyl group). The data of this study contribute to a better understanding of the molecular mechanism of action of Lycii Radicis Cortex extracts in the context of inflammation.
Using activity-guided fractionation, phenolic amides (such as trans-N-caffeoyltyramine) were confirmed as main components from |
doi_str_mv | 10.1016/j.jep.2014.01.029 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1508426001</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378874114000762</els_id><sourcerecordid>1508426001</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-ea574f0a6988e950c7fe668891d68aba24c4fa367342473f620b82dffde63fbf3</originalsourceid><addsrcrecordid>eNp9kM1u1DAURi1ERaeFB2CDvGST4L_EHrEaqpYiDW1Vwdpy7OuOhyQebKfSPBc7HqLPREZTWLK6m_Md6R6E3lJSU0LbD9t6C7uaESpqQmvCli_QgirJKtlI_hItCJeqUlLQU3SW85YQIqkgr9ApEw1lkssFiitbwmMo--phCg4cDjn2poQ44ujxzVX19PsTDuMmdKHElLEZHb67W90__cLmIY4hl4x9igMuG8ApxoI7k34ctuu9DdOA7SaMMGbAX0PfQ3qNTrzpM7x5vufo-9Xlt4vran37-cvFal1Z3vBSgWmk8MS0S6Vg2RArPbStUkvqWmU6w4QV3vBWcsGE5L5lpFPMee-g5b7z_By9P3p3Kf6cIBc9hGyh780IccqaNkQJ1hJCZ5QeUZtizgm83qUwmLTXlOhDZ73Vc2d96KwJ1XPnefPuWT91A7h_i79hZ-DjEYD5yccASWcbYLTgQgJbtIvhP_o_9vePqg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1508426001</pqid></control><display><type>article</type><title>Activity-guided isolation of NF-κB inhibitors and PPARγ agonists from the root bark of Lycium chinense Miller</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Xie, Lian-Wu ; Atanasov, Atanas G. ; Guo, De-An ; Malainer, Clemens ; Zhang, Jing-Xian ; Zehl, Martin ; Guan, Shu-Hong ; Heiss, Elke H. ; Urban, Ernst ; Dirsch, Verena M. ; Kopp, Brigitte</creator><creatorcontrib>Xie, Lian-Wu ; Atanasov, Atanas G. ; Guo, De-An ; Malainer, Clemens ; Zhang, Jing-Xian ; Zehl, Martin ; Guan, Shu-Hong ; Heiss, Elke H. ; Urban, Ernst ; Dirsch, Verena M. ; Kopp, Brigitte</creatorcontrib><description>The root bark of Lycium chinense Miller, Lycii Radicis Cortex, has been used in traditional Chinese medicine (TCM) to treat different inflammation-related symptoms, such as diabetes mellitus. The pro-inflammatory transcription factor nuclear factor kappa B (NF-κB) is a key regulator of inflammation, while the transcription factor peroxisome proliferator-activated receptor gamma (PPARγ) is a key modulator of genes involved in diabetes development. To identify putative active compound(s) from Lycii Radicis Cortex inhibiting NF-κB or activating PPARγ.
Using activity-guided fractionation, six extracts with different polarity, isolated fractions, and purified compounds from Lycii Radicis Cortex were tested for NF-κB inhibition and PPARγ activation in vitro. The structure of the purified compounds was elucidated by NMR and MS techniques.
The ethyl acetate extract and the methanol extract of Lycii Radicis Cortex suppressed tumor necrosis factor alpha (TNF-α)-induced activation of NF-κB, while the dichloromethane extract activated PPARγ. Nine phenolic amide analogues, including trans-N-(p-coumaroyl)tyramine (1), trans-N-feruloyltyramine (2), trans-N-caffeoyltyramine (3), dihydro-N-caffeoyltyramine (4), three neolignanamides (5–7), and two lignanamide (8, 9), were isolated and their inhibitory potential on NF-κB was determined (1–4 were also contained in water decoction). Two of the nine isolated phenolic amides inhibited TNF-α-induced NF-κB activation. Trans-N-caffeoyltyramine was verified as the key component responsible for the NF-κB inhibition with an IC50 of 18.4μM in our cell-based test system. Activation of PPARγ was attributed to a palmitic-acid enriched fraction which displayed concentration-dependent effect ablated upon co-treatment with the PPARγ antagonist T0070907.
Phenolic amides were confirmed as main components from Lycii Radicis Cortex responsible for NF-κB inhibition. Fatty acids were identified as the major plant constituent responsible for the PPARγ activation. Structure-activity relationship analysis suggests that the NF-κB inhibitory activity of trans-N-caffeoyltyramine may be attributed to its Michael acceptor-type structure (α,β-unsaturated carbonyl group). The data of this study contribute to a better understanding of the molecular mechanism of action of Lycii Radicis Cortex extracts in the context of inflammation.
Using activity-guided fractionation, phenolic amides (such as trans-N-caffeoyltyramine) were confirmed as main components from Cortex Lycii responsible for NF-κB inhibition. Fatty acids were identified as the major plant constituent responsible for the PPARγ activation. [Display omitted]</description><identifier>ISSN: 0378-8741</identifier><identifier>EISSN: 1872-7573</identifier><identifier>DOI: 10.1016/j.jep.2014.01.029</identifier><identifier>PMID: 24512737</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject><![CDATA[Amides - isolation & purification ; Amides - pharmacology ; Fatty acids ; Fatty Acids - isolation & purification ; Fatty Acids - pharmacology ; Humans ; Inhibitory Concentration 50 ; Lycii Radicis Cortex ; Lycium - chemistry ; Lycium chinense Miller ; Magnetic Resonance Spectroscopy ; Mass Spectrometry ; Medicine, Chinese Traditional ; NF-kappa B - antagonists & inhibitors ; NF-κB ; Phenolic amides ; Phenols - isolation & purification ; Phenols - pharmacology ; Plant Bark ; Plant Extracts - administration & dosage ; Plant Extracts - pharmacology ; Plant Roots ; PPAR gamma - agonists ; PPARγ ; Structure-Activity Relationship ; Tumor Necrosis Factor-alpha - administration & dosage]]></subject><ispartof>Journal of ethnopharmacology, 2014-03, Vol.152 (3), p.470-477</ispartof><rights>2014 Elsevier Ireland Ltd</rights><rights>Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-ea574f0a6988e950c7fe668891d68aba24c4fa367342473f620b82dffde63fbf3</citedby><cites>FETCH-LOGICAL-c353t-ea574f0a6988e950c7fe668891d68aba24c4fa367342473f620b82dffde63fbf3</cites><orcidid>0000-0001-9685-0373</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jep.2014.01.029$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24512737$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xie, Lian-Wu</creatorcontrib><creatorcontrib>Atanasov, Atanas G.</creatorcontrib><creatorcontrib>Guo, De-An</creatorcontrib><creatorcontrib>Malainer, Clemens</creatorcontrib><creatorcontrib>Zhang, Jing-Xian</creatorcontrib><creatorcontrib>Zehl, Martin</creatorcontrib><creatorcontrib>Guan, Shu-Hong</creatorcontrib><creatorcontrib>Heiss, Elke H.</creatorcontrib><creatorcontrib>Urban, Ernst</creatorcontrib><creatorcontrib>Dirsch, Verena M.</creatorcontrib><creatorcontrib>Kopp, Brigitte</creatorcontrib><title>Activity-guided isolation of NF-κB inhibitors and PPARγ agonists from the root bark of Lycium chinense Miller</title><title>Journal of ethnopharmacology</title><addtitle>J Ethnopharmacol</addtitle><description>The root bark of Lycium chinense Miller, Lycii Radicis Cortex, has been used in traditional Chinese medicine (TCM) to treat different inflammation-related symptoms, such as diabetes mellitus. The pro-inflammatory transcription factor nuclear factor kappa B (NF-κB) is a key regulator of inflammation, while the transcription factor peroxisome proliferator-activated receptor gamma (PPARγ) is a key modulator of genes involved in diabetes development. To identify putative active compound(s) from Lycii Radicis Cortex inhibiting NF-κB or activating PPARγ.
Using activity-guided fractionation, six extracts with different polarity, isolated fractions, and purified compounds from Lycii Radicis Cortex were tested for NF-κB inhibition and PPARγ activation in vitro. The structure of the purified compounds was elucidated by NMR and MS techniques.
The ethyl acetate extract and the methanol extract of Lycii Radicis Cortex suppressed tumor necrosis factor alpha (TNF-α)-induced activation of NF-κB, while the dichloromethane extract activated PPARγ. Nine phenolic amide analogues, including trans-N-(p-coumaroyl)tyramine (1), trans-N-feruloyltyramine (2), trans-N-caffeoyltyramine (3), dihydro-N-caffeoyltyramine (4), three neolignanamides (5–7), and two lignanamide (8, 9), were isolated and their inhibitory potential on NF-κB was determined (1–4 were also contained in water decoction). Two of the nine isolated phenolic amides inhibited TNF-α-induced NF-κB activation. Trans-N-caffeoyltyramine was verified as the key component responsible for the NF-κB inhibition with an IC50 of 18.4μM in our cell-based test system. Activation of PPARγ was attributed to a palmitic-acid enriched fraction which displayed concentration-dependent effect ablated upon co-treatment with the PPARγ antagonist T0070907.
Phenolic amides were confirmed as main components from Lycii Radicis Cortex responsible for NF-κB inhibition. Fatty acids were identified as the major plant constituent responsible for the PPARγ activation. Structure-activity relationship analysis suggests that the NF-κB inhibitory activity of trans-N-caffeoyltyramine may be attributed to its Michael acceptor-type structure (α,β-unsaturated carbonyl group). The data of this study contribute to a better understanding of the molecular mechanism of action of Lycii Radicis Cortex extracts in the context of inflammation.
Using activity-guided fractionation, phenolic amides (such as trans-N-caffeoyltyramine) were confirmed as main components from Cortex Lycii responsible for NF-κB inhibition. Fatty acids were identified as the major plant constituent responsible for the PPARγ activation. [Display omitted]</description><subject>Amides - isolation & purification</subject><subject>Amides - pharmacology</subject><subject>Fatty acids</subject><subject>Fatty Acids - isolation & purification</subject><subject>Fatty Acids - pharmacology</subject><subject>Humans</subject><subject>Inhibitory Concentration 50</subject><subject>Lycii Radicis Cortex</subject><subject>Lycium - chemistry</subject><subject>Lycium chinense Miller</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Mass Spectrometry</subject><subject>Medicine, Chinese Traditional</subject><subject>NF-kappa B - antagonists & inhibitors</subject><subject>NF-κB</subject><subject>Phenolic amides</subject><subject>Phenols - isolation & purification</subject><subject>Phenols - pharmacology</subject><subject>Plant Bark</subject><subject>Plant Extracts - administration & dosage</subject><subject>Plant Extracts - pharmacology</subject><subject>Plant Roots</subject><subject>PPAR gamma - agonists</subject><subject>PPARγ</subject><subject>Structure-Activity Relationship</subject><subject>Tumor Necrosis Factor-alpha - administration & dosage</subject><issn>0378-8741</issn><issn>1872-7573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1u1DAURi1ERaeFB2CDvGST4L_EHrEaqpYiDW1Vwdpy7OuOhyQebKfSPBc7HqLPREZTWLK6m_Md6R6E3lJSU0LbD9t6C7uaESpqQmvCli_QgirJKtlI_hItCJeqUlLQU3SW85YQIqkgr9ApEw1lkssFiitbwmMo--phCg4cDjn2poQ44ujxzVX19PsTDuMmdKHElLEZHb67W90__cLmIY4hl4x9igMuG8ApxoI7k34ctuu9DdOA7SaMMGbAX0PfQ3qNTrzpM7x5vufo-9Xlt4vran37-cvFal1Z3vBSgWmk8MS0S6Vg2RArPbStUkvqWmU6w4QV3vBWcsGE5L5lpFPMee-g5b7z_By9P3p3Kf6cIBc9hGyh780IccqaNkQJ1hJCZ5QeUZtizgm83qUwmLTXlOhDZ73Vc2d96KwJ1XPnefPuWT91A7h_i79hZ-DjEYD5yccASWcbYLTgQgJbtIvhP_o_9vePqg</recordid><startdate>20140328</startdate><enddate>20140328</enddate><creator>Xie, Lian-Wu</creator><creator>Atanasov, Atanas G.</creator><creator>Guo, De-An</creator><creator>Malainer, Clemens</creator><creator>Zhang, Jing-Xian</creator><creator>Zehl, Martin</creator><creator>Guan, Shu-Hong</creator><creator>Heiss, Elke H.</creator><creator>Urban, Ernst</creator><creator>Dirsch, Verena M.</creator><creator>Kopp, Brigitte</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9685-0373</orcidid></search><sort><creationdate>20140328</creationdate><title>Activity-guided isolation of NF-κB inhibitors and PPARγ agonists from the root bark of Lycium chinense Miller</title><author>Xie, Lian-Wu ; Atanasov, Atanas G. ; Guo, De-An ; Malainer, Clemens ; Zhang, Jing-Xian ; Zehl, Martin ; Guan, Shu-Hong ; Heiss, Elke H. ; Urban, Ernst ; Dirsch, Verena M. ; Kopp, Brigitte</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-ea574f0a6988e950c7fe668891d68aba24c4fa367342473f620b82dffde63fbf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Amides - isolation & purification</topic><topic>Amides - pharmacology</topic><topic>Fatty acids</topic><topic>Fatty Acids - isolation & purification</topic><topic>Fatty Acids - pharmacology</topic><topic>Humans</topic><topic>Inhibitory Concentration 50</topic><topic>Lycii Radicis Cortex</topic><topic>Lycium - chemistry</topic><topic>Lycium chinense Miller</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Mass Spectrometry</topic><topic>Medicine, Chinese Traditional</topic><topic>NF-kappa B - antagonists & inhibitors</topic><topic>NF-κB</topic><topic>Phenolic amides</topic><topic>Phenols - isolation & purification</topic><topic>Phenols - pharmacology</topic><topic>Plant Bark</topic><topic>Plant Extracts - administration & dosage</topic><topic>Plant Extracts - pharmacology</topic><topic>Plant Roots</topic><topic>PPAR gamma - agonists</topic><topic>PPARγ</topic><topic>Structure-Activity Relationship</topic><topic>Tumor Necrosis Factor-alpha - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xie, Lian-Wu</creatorcontrib><creatorcontrib>Atanasov, Atanas G.</creatorcontrib><creatorcontrib>Guo, De-An</creatorcontrib><creatorcontrib>Malainer, Clemens</creatorcontrib><creatorcontrib>Zhang, Jing-Xian</creatorcontrib><creatorcontrib>Zehl, Martin</creatorcontrib><creatorcontrib>Guan, Shu-Hong</creatorcontrib><creatorcontrib>Heiss, Elke H.</creatorcontrib><creatorcontrib>Urban, Ernst</creatorcontrib><creatorcontrib>Dirsch, Verena M.</creatorcontrib><creatorcontrib>Kopp, Brigitte</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of ethnopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xie, Lian-Wu</au><au>Atanasov, Atanas G.</au><au>Guo, De-An</au><au>Malainer, Clemens</au><au>Zhang, Jing-Xian</au><au>Zehl, Martin</au><au>Guan, Shu-Hong</au><au>Heiss, Elke H.</au><au>Urban, Ernst</au><au>Dirsch, Verena M.</au><au>Kopp, Brigitte</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activity-guided isolation of NF-κB inhibitors and PPARγ agonists from the root bark of Lycium chinense Miller</atitle><jtitle>Journal of ethnopharmacology</jtitle><addtitle>J Ethnopharmacol</addtitle><date>2014-03-28</date><risdate>2014</risdate><volume>152</volume><issue>3</issue><spage>470</spage><epage>477</epage><pages>470-477</pages><issn>0378-8741</issn><eissn>1872-7573</eissn><abstract>The root bark of Lycium chinense Miller, Lycii Radicis Cortex, has been used in traditional Chinese medicine (TCM) to treat different inflammation-related symptoms, such as diabetes mellitus. The pro-inflammatory transcription factor nuclear factor kappa B (NF-κB) is a key regulator of inflammation, while the transcription factor peroxisome proliferator-activated receptor gamma (PPARγ) is a key modulator of genes involved in diabetes development. To identify putative active compound(s) from Lycii Radicis Cortex inhibiting NF-κB or activating PPARγ.
Using activity-guided fractionation, six extracts with different polarity, isolated fractions, and purified compounds from Lycii Radicis Cortex were tested for NF-κB inhibition and PPARγ activation in vitro. The structure of the purified compounds was elucidated by NMR and MS techniques.
The ethyl acetate extract and the methanol extract of Lycii Radicis Cortex suppressed tumor necrosis factor alpha (TNF-α)-induced activation of NF-κB, while the dichloromethane extract activated PPARγ. Nine phenolic amide analogues, including trans-N-(p-coumaroyl)tyramine (1), trans-N-feruloyltyramine (2), trans-N-caffeoyltyramine (3), dihydro-N-caffeoyltyramine (4), three neolignanamides (5–7), and two lignanamide (8, 9), were isolated and their inhibitory potential on NF-κB was determined (1–4 were also contained in water decoction). Two of the nine isolated phenolic amides inhibited TNF-α-induced NF-κB activation. Trans-N-caffeoyltyramine was verified as the key component responsible for the NF-κB inhibition with an IC50 of 18.4μM in our cell-based test system. Activation of PPARγ was attributed to a palmitic-acid enriched fraction which displayed concentration-dependent effect ablated upon co-treatment with the PPARγ antagonist T0070907.
Phenolic amides were confirmed as main components from Lycii Radicis Cortex responsible for NF-κB inhibition. Fatty acids were identified as the major plant constituent responsible for the PPARγ activation. Structure-activity relationship analysis suggests that the NF-κB inhibitory activity of trans-N-caffeoyltyramine may be attributed to its Michael acceptor-type structure (α,β-unsaturated carbonyl group). The data of this study contribute to a better understanding of the molecular mechanism of action of Lycii Radicis Cortex extracts in the context of inflammation.
Using activity-guided fractionation, phenolic amides (such as trans-N-caffeoyltyramine) were confirmed as main components from Cortex Lycii responsible for NF-κB inhibition. Fatty acids were identified as the major plant constituent responsible for the PPARγ activation. [Display omitted]</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>24512737</pmid><doi>10.1016/j.jep.2014.01.029</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-9685-0373</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0378-8741 |
ispartof | Journal of ethnopharmacology, 2014-03, Vol.152 (3), p.470-477 |
issn | 0378-8741 1872-7573 |
language | eng |
recordid | cdi_proquest_miscellaneous_1508426001 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Amides - isolation & purification Amides - pharmacology Fatty acids Fatty Acids - isolation & purification Fatty Acids - pharmacology Humans Inhibitory Concentration 50 Lycii Radicis Cortex Lycium - chemistry Lycium chinense Miller Magnetic Resonance Spectroscopy Mass Spectrometry Medicine, Chinese Traditional NF-kappa B - antagonists & inhibitors NF-κB Phenolic amides Phenols - isolation & purification Phenols - pharmacology Plant Bark Plant Extracts - administration & dosage Plant Extracts - pharmacology Plant Roots PPAR gamma - agonists PPARγ Structure-Activity Relationship Tumor Necrosis Factor-alpha - administration & dosage |
title | Activity-guided isolation of NF-κB inhibitors and PPARγ agonists from the root bark of Lycium chinense Miller |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T21%3A05%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activity-guided%20isolation%20of%20NF-%CE%BAB%20inhibitors%20and%20PPAR%CE%B3%20agonists%20from%20the%20root%20bark%20of%20Lycium%20chinense%20Miller&rft.jtitle=Journal%20of%20ethnopharmacology&rft.au=Xie,%20Lian-Wu&rft.date=2014-03-28&rft.volume=152&rft.issue=3&rft.spage=470&rft.epage=477&rft.pages=470-477&rft.issn=0378-8741&rft.eissn=1872-7573&rft_id=info:doi/10.1016/j.jep.2014.01.029&rft_dat=%3Cproquest_cross%3E1508426001%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1508426001&rft_id=info:pmid/24512737&rft_els_id=S0378874114000762&rfr_iscdi=true |